• Robin's News & Noticias
    Robin's News & Noticias
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • 2018 FIFA World Cup
    2018 FIFA World Cup
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

Thu07192018

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability
XMT-1522 Demonstrates Synergy in Combination with a Checkpoint InhibitorCAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin and other proprietary platforms, today announced new data on Mersana’s lead ADC platform, Dolaflexin, and on the HER2 targeted ADC XMT-1522, presented as part of the 2018 American Association for Cancer Research (AACR) Annual Meeting bei...


Posted: 2018-04-17 17:01:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018 | Globe NewsWire News Distribution Service - Newscast

Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

Tue, 17 Apr 2018 10:11:00 GMT

CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody d...

Sareum : AACR 2018 Update

Mon, 16 Apr 2018 17:00:00 GMT

Sareum Notes that Sierra Oncology will Present Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARP Inhibitors at the AACR 2018 Annual Meeting Two ... The Company's drug discovery te...

AACR 2018 Update

Mon, 16 Apr 2018 17:00:00 GMT

Sareum Notes that Sierra Oncology will Present Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARP Inhibitors at the AACR 2018 Annual Meeting Two ... The Company's drug discovery te...

Mersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018

Mon, 16 Apr 2018 17:00:00 GMT

Detailed Characterization of Unique DolaLock Technology Enhancements to Drug Efficacy and Tolerability XMT-1522 Demonstrates Synergy in Combination with a Checkpoint Inhibitor CAMBRIDGE, Mass., April ...

MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones

Mon, 02 Apr 2018 04:44:00 GMT

We look forward to continuing enrollment in each program and participating in key scientific conferences over the course of 2018, including our upcoming presentation of new data at AACR ... to retain ...

Related Bing Web Search

Pharmaceutical Conferences - Drug Conferences | 2018 | 2019

(Wed, 11 Jul 2018 13:06:00 GMT)

Welcome to The Pharmaceutical Conferences. Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Crown Bioscience Oncology & CVMD Models

(Mon, 16 Jul 2018 23:59:00 GMT)

Presented by Dr Henry Li, this webinar explores the detailed data analysis behind the industry's first large-scale, staggered, syngeneic screening platform for immunotherapy development.

Conference Program | ICST 2018 | May | Rome Italy

(Sun, 15 Jul 2018 13:01:00 GMT)

3rd International Cancer Study & Therapy Conference . May 2-4, 2018 | Rome, Italy . Collaborated with WAMS, The World Academy of Medical Sciences

BioTek Instruments

(Tue, 17 Jul 2018 13:13:00 GMT)

BioTek Instruments, Inc. is a global leader in the development, manufacture and sale of life science instrumentation, including imaging & microscopy, multi-mode detection, liquid handling and automation systems.

Vaccines Congress 2018 - Vaccines and Immunization

(Sat, 14 Jul 2018 15:19:00 GMT)

Vaccines conferences, Immunology Conferences, Vaccines Congress 2018 organizing at Osaka, Japan will bring global experts from Asia, Europe, USA & Middle East to discuss on Vaccines & Immunization

GRAIL | Combining Science, Tech and Clinical Studies to ...

(Sun, 15 Jul 2018 20:47:00 GMT)

GRAIL is taking on one of the biggest challenges of our lifetime, combining science, technology, and clinical studies to reveal cancer at its beginnings.

Vividion Therapeutics: Creating a New Era in Drug Discovery

(Thu, 12 Jul 2018 06:03:00 GMT)

Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery.

Life extension - Wikipedia

(Sun, 15 Jul 2018 09:55:00 GMT)

Another proposed life extension technology would combine existing and predicted future biochemical and genetic techniques. SENS proposes that rejuvenation may be obtained by removing aging damage via the use of stem cells and tissue engineering, telomere-lengthening machinery, allotopic expression of mitochondrial proteins, targeted ablation of ...

Chimeric antigen receptor - Wikipedia

(Fri, 13 Jul 2018 21:25:00 GMT)

Chimeric antigen receptors (CARs, also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors) are engineered receptors that combine a new specificity with an immune cell to target cancer cells.

About Us – Neon

(Tue, 10 Jul 2018 13:50:00 GMT)

Neon Therapeutics is a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens.

Related News Story Videos From Youtube

Translating the cancer genome: transforming cancer care


Related Videos On: Translating the cancer genome: transforming cancer care


TRACO 2017 - Clinical trials and Precision Medicine


Related Videos On: TRACO 2017 - Clinical trials and Precision Medicine


019 Insight into IVD Device Development with John and Jenn Zeis


Related Videos On: 019 Insight into IVD Device Development with John and Jenn Zeis






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
Copyright; 2008-2018 RobinsPost (The Bird's Eye View Company) All rights reserved.
RobinsPost.com provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by respective news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST.COM Is Proudly Made In America.
Where Quality, Safety and Service Comes First.